Replimune Group Inc (REPL)
6.42
+0.27
(+4.39%)
USD |
NASDAQ |
Apr 26, 16:00
6.40
-0.02
(-0.31%)
After-Hours: 20:00
Replimune Group Price to Book Value: 0.9349 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 0.9349 |
| April 25, 2024 | 0.8956 |
| April 24, 2024 | 0.9218 |
| April 23, 2024 | 0.9349 |
| April 22, 2024 | 0.9349 |
| April 19, 2024 | 0.9393 |
| April 18, 2024 | 1.015 |
| April 17, 2024 | 1.05 |
| April 16, 2024 | 1.041 |
| April 15, 2024 | 1.037 |
| April 12, 2024 | 1.040 |
| April 11, 2024 | 1.047 |
| April 10, 2024 | 1.014 |
| April 09, 2024 | 1.060 |
| April 08, 2024 | 1.037 |
| April 05, 2024 | 1.072 |
| April 04, 2024 | 1.069 |
| April 03, 2024 | 1.028 |
| April 02, 2024 | 1.038 |
| April 01, 2024 | 1.126 |
| March 28, 2024 | 1.190 |
| March 27, 2024 | 1.201 |
| March 26, 2024 | 1.120 |
| March 25, 2024 | 1.172 |
| March 22, 2024 | 1.194 |
| Date | Value |
|---|---|
| March 21, 2024 | 1.194 |
| March 20, 2024 | 1.181 |
| March 19, 2024 | 1.203 |
| March 18, 2024 | 1.206 |
| March 15, 2024 | 1.242 |
| March 14, 2024 | 1.287 |
| March 13, 2024 | 1.308 |
| March 12, 2024 | 1.267 |
| March 11, 2024 | 1.289 |
| March 08, 2024 | 1.315 |
| March 07, 2024 | 1.287 |
| March 06, 2024 | 1.312 |
| March 05, 2024 | 1.254 |
| March 04, 2024 | 1.293 |
| March 01, 2024 | 1.306 |
| February 29, 2024 | 1.250 |
| February 28, 2024 | 1.268 |
| February 27, 2024 | 1.290 |
| February 26, 2024 | 1.254 |
| February 23, 2024 | 1.198 |
| February 22, 2024 | 1.158 |
| February 21, 2024 | 1.113 |
| February 20, 2024 | 1.114 |
| February 16, 2024 | 1.126 |
| February 15, 2024 | 1.116 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.857
Minimum
Dec 05 2023
9.258
Maximum
Dec 01 2020
2.874
Average
2.728
Median
Mar 03 2020
Price to Book Value Benchmarks
| Esperion Therapeutics Inc | -- |
| Gossamer Bio Inc | 2.401 |
| NovaBay Pharmaceuticals Inc | 1.739 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6668 |
Price to Book Value Related Metrics
| Price | 6.42 |
| Earnings Yield | -49.22% |
| Market Cap | 394.11M |